Dubai  — An experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) has 86% efficacy, the health ministry of the United Arab Emirates (UAE) said on Wednesday, citing an interim analysis of late-stage clinical trials.

While the positive data comes soon after November's upbeat results from Western rivals, such as Pfizer, Moderna, AstraZeneca  and from Russia, neither the UAE nor Sinopharm have released detailed data from the pivotal study...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.